News & Announcements
Latest accomplishments highlighting STSI in the media
Categories
Monthly Archives
- October, 2010
- September, 2010
- August, 2010
- July, 2010
- June, 2010
- May, 2010
- March, 2010
- February, 2010
- January, 2010
- November, 2009
- October, 2009
- August, 2009
- June, 2009
- February, 2009
- October, 2008
- September, 2008
- August, 2008
News & Announcements Feed
News & Announcements
October 07, 2010
“Wireless health gathering features radio pill”—San Diego Union Tribune
“This is a different era in medicine,” Eric J. Topol, M.D., said at the Wireless Health 2010 conference. “This is a consumer story. Individuals will be taking charge of their health.”
Dr. Topol, Director of the Scripps Translational Science Institute, is Chief Innovation Officer at West Wireless Health Institute, also in La Jolla.
October 04, 2010
Scripps-Led Study Validates Gene Expression Test for Diagnosing Obstructive Coronary Artery Disease
A new study led by researchers at the Scripps Translational Science Institute validates that a promising gene expression test may be useful in helping doctors sort out which patients are the best candidates for angiograms, and who can potentially be spared the invasive diagnostic procedures.
September 22, 2010
Genetic variations linked to cardiovascular disease risk factors from childhood to adulthood
Common variants that can be identified in a child’s DNA may help predict the genetic predisposition for developing cardiovascular disease (CVD) risk factors later in life, according to research findings published in a Sept. 2010 issue of PLoS Genetics. The research project, headed by scientists at Scripps Translational Science Institute, is the first genome-wide association study to evaluate the role of common genetic variants in the development of CVD risk factors in adults whose health has been tracked from childhood.
September 15, 2010
Consumers have concerns about home genetic tests
the Sept. 2010 issue of Genetics in Medicine, Scripps Translational Science Institute scientists report that 50% of people using direct-to-consumer personal genetic risk tests express concerns about testing — yet more than 80% want to know their risk even for non-preventable genetic diseases.
August 12, 2010
The Economist: “Personal genetic-testing industry is under fire, but happier days lie ahead”
So far, direct-to-consumer genetics firms have struggled to make money, according to an Aug. 12, 2010 article in The Economist. Dr. Eric Topol, STSI’s Director, is quoted as estimating that only about 100,000 people have paid for these genetic tests.
August 11, 2010
Docs falling behind in race to help patients with genetics
Dr. Eric Topol’s commentary, “Pharmacy Benefit Managers, Pharmacies, and Pharmacogenomic Testing: Prescription for Progress?”, in the Aug. 11, 2010 issue of Science Translational Medicine, generated several news articles as well as a San Diego Union Tribune essay by the STSI Director. “While physicians and the life science industry have done little to advance the use of testing for drug-gene interactions, now the pharmacy benefit managers (PBMs) Medco and CVS/Caremark, which collectively administer the employer prescription plans for nearly 100 million Americans, are stepping up,” Dr. Topol wrote in the essay.
August 10, 2010
Scripps Genomic Medicine partners with Sanofi-aventis to advance individualized medicine
Sanofi-aventis and Scripps Genomic Medicine announced a strategic alliance to advance research and development initiatives in the field of individualized medicine. Eric Topol, M.D., Chief Academic Officer of Scripps Health and Director of Scripps Genomic Medicine and the Scripps Translational Science Institute, said, “The partnership aims to foster an environment of open scientific exchange in genomic medicine that we hope will translate to new discoveries to benefit patients while establishing a collaborative approach to drug development.”
August 02, 2010
August 02, 2010
July 28, 2010
“Cost of Discovery” 2-page feature article in San Diego Union-Tribune, July 2010
“Cost of discovery”
A glimpse at why research in the life sciences is so expensive
By Gary Robbins, Union-Tribune Staff Writer
July 25, 2010
June 29, 2010
June 03, 2010
Dr. Eric Topol recently quoted in Science article on GWAS
Major Heart Disease Genes Prove Elusive
So far, genome-wide association studies have not found common genes with a big impact on heart health; researchers hope that the low-effect genes they are finding will help identify pathways and drug targets.
May 10, 2010
Genomeweb Interview with Dr. Eric Topol, ‘Genomic Medicine Academy’ and Getting Docs Excited About M
March 31, 2010
March 08, 2010
